Status:
NOT_YET_RECRUITING
Assessing the Time-Course of Dexmedetomidine-Induced Analgesia Via EEG
Lead Sponsor:
China International Neuroscience Institution
Conditions:
Total Hip Arthroplasty (THA)
Intrathecal Anesthesia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Objective: To investigate the temporal dynamics of dexmedetomidine's analgesic effects in the brain using EEG. Methods: Eligible patients scheduled for total hip arthroplasty under intrathecal anesth...
Detailed Description
Objective: To investigate the temporal dynamics of dexmedetomidine's analgesic effects in the brain using EEG. Methods: Eligible patients scheduled for total hip arthroplasty under intrathecal anesth...
Eligibility Criteria
Inclusion
- Patients with hip osteoarthritis scheduled for total hip arthroplasty under intrathecal anesthesia; Age 18-70 years; American Society of Anesthesiologists (ASA) physical status classification I-III; Body mass index (BMI) 22-30 kg/m².
Exclusion
- Pre-existing peripheral or central nervous system disorders; Mental disorders; Cognitive impairment; Emergency surgery; or Hearing impairment.
Key Trial Info
Start Date :
April 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 26 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06946277
Start Date
April 25 2025
End Date
May 26 2025
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu hospital
Beijing, Beijing Municipality, China, 100053